The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive alternative to glasses or surgery. Phase 3 trials demonstrated superior ...
ONE of the least discussed parts of Britain’s Strategic Defence Review announced last June was the additional role that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results